RxDoctor Payments Data

Michele Dickison, NP

Nurse Practitioner · Lewiston, IDNPI 1841687001

Payments from drug & device makers

$780in general payments, 2019–2025

Across 35 payments — averaging $22.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • E.r. Squibb & Sons, L.L.C.$127
  • Genentech USA, Inc.$106
  • Johnson & Johnson$92
  • AstraZeneca$70
  • Sanofi$67
  • AVEO Pharmaceuticals, Inc.$59
  • plus $260 from 10 others

What the payments were for

  • Food & beverage$780100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$780 in reported general payments places this provider in the 75th percentile of 570 nurse practitioner providers in Idaho.

See all nurse practitioner providers in Idaho

Medicare billing

Part B allowed, 2024
$61,811
Medicare patients
360
Services billed
679

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
RevlimidLenalidomide20$486,823
Lenalidomide25$384,757
ImbruvicaIbrutinib29$344,732
RezurockBelumosudil Mesylate12$216,643
Abiraterone Acetate24$33,206
Atovaquone11$18,373
Exemestane31$4,103
Anastrozole170$3,534
Tamoxifen Citrate68$1,894
Letrozole39$1,525
Hydroxyurea29$1,505
Gabapentin35$1,006
Estradiol16$955
Acyclovir26$531
Oxycodone Hcl22$506

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Bristol Myers SquibbRevlimid$48$486,82320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 570 nurse practitioner providers in Idaho.

Other nurse practitioner in Lewiston

See the full list for Idaho

Where these figures come from

Is this you, or does something look wrong? →